Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study. Lancet Psychiatry. 2026 13(8):669-677.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. Lancet Reg Health Eur. 2026 65:101658.
Geissler CJ, Lim TV, Görne HA, Krenkel S, Büchel C, Ersche KD. Increased Avoidance Learning in Chronic Opioid Users. JAMA Psychiatry. 2026 83(3):292-297. Epub 2025 Nov 6.
Salamian A, Pagano R, Skonieczna E, Kalinichenko LS, Puchalska M, Yiğit Ünlü G, Gajewska-Woźniak O, Kruashvili L, Grochowicz M, Wojtas B, Gielniewski B, Harda Z, Cały A, Mühle C, Lenz B, Kornhuber J, Lourdusamy A, Havekes R, Abel T, Müller CP, Radwanska K. Hippocampal Cofilin and CFL1 gene variants are linked to Alcohol Use Disorder phenotypes. Mol Psychiatry. 2026 31(3):1216-1230. Epub 2025 Sep 11.
Stürzenberger S, Bülow N, Kalinichenko LS, Licha R, Eulenburg V, Dahlmanns M, Müller CP, Zheng F, Alzheimer C. Heavy adolescent drinking makes the adult brain more vulnerable to ethanol by permanently altering the age-dependent interplay between alcohol, GIRK channels and activin. Mol Psychiatry. 2026 31(2):1027-1040.